Doctor profile · Federal record
Dr. Caitlin Fink, D.O.
Dermatology Physician (CMS: Dermatology) · Bethesda, MD
- NPI 1093022915
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8901 Wisconsin Ave
Bethesda, MD 208890004
(301) 295-4551
Credentials & registration
- NPI registered
- September 2010 — 16 yrs on file
- Profile last updated
- March 21, 2017
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Maryland #H83043
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093022915. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,663
Distinct HCPCS
10
Medicare allowed
$140,335
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 472 | 319 | $105 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 315 | 77 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 204 | 124 | $69 | |
17110 |
Destruction of skin growth, 1-14 growths | 153 | 106 | $132 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 133 | 104 | $66 | |
11102 |
Biopsy of related skin growth, first growth | 96 | 92 | $114 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 85 | 85 | $133 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 56 | 33 | $140 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 46 | 16 | $1 | |
10040 |
Acne surgery | 23 | 16 | $140 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 158. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$1,351
Transactions
75
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $224.23 | |
| ABBVIE INC. | 12 | $206.81 | |
| Janssen Biotech, Inc. | 7 | $196.30 | |
| GENZYME CORPORATION | 6 | $118.48 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $91.78 | |
| Dermavant Sciences, Inc. | 5 | $89.15 | |
| LEO Pharma Inc. | 4 | $89.00 | |
| Blueprint Medicines Corporation | 3 | $73.43 | |
| PFIZER INC. | 4 | $57.37 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $53.34 | |
| Galderma Laboratories, L.P. | 2 | $35.72 | |
| Arcutis Biotherapeutics, Inc. | 2 | $32.20 | |
| Lilly USA, LLC | 2 | $28.29 | |
| Amgen Inc. | 1 | $27.82 | |
| Novartis Pharmaceuticals Corporation | 1 | $27.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
670
Patients
362
Total drug cost
$28,567
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 103 | 75 | $1,889 |
| Ketoconazole | Generic | 102 | 47 | $2,024 |
| Betamethasone Dipropionate | Generic | 97 | 51 | $5,423 |
| Clobetasol Propionate | Generic | 53 | 28 | $4,981 |
| Nystatin | Generic | 50 | 31 | $702 |
| Mupirocin | Generic | 42 | 29 | $387 |
| Hydrocortisone | Generic | 38 | 23 | $393 |
| Fluocinonide | Generic | 33 | 14 | $2,329 |
| Halobetasol Propionate | Generic | 30 | 21 | $2,820 |
| Metronidazole | Generic | 28 | 15 | $2,229 |
Frequently asked questions
What is Dr. Caitlin Fink's medical specialty?
Dr. Caitlin Fink practices Dermatology Physician in Bethesda, MD.
Where does Dr. Caitlin Fink practice?
Dr. Caitlin Fink practices at 8901 Wisconsin Ave, Bethesda, MD 208890004. Office phone: 3012954551.
What is Dr. Caitlin Fink's NPI?
Dr. Caitlin Fink's National Provider Identifier (NPI) is 1093022915, issued by NPPES.
Does Dr. Caitlin Fink accept Medicare assignment?
Yes. Dr. Caitlin Fink accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Caitlin Fink commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.